Posted by Michael Wonder on 18 Feb 2020
FDA calls states’ bluffs on drug importation
18 February 2020 - For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada as a convenient shortcut to lower prices.
The Food and Drug Administration’s recent release of a proposed regulation to create a process for approving state-sponsored importation plans is one step closer to that goal.
A closer look shows that it’s actually a false step.
